Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue, net:
Core companion animal health	$ 19,572	$ 17,366
Other vaccines, pharmaceuticals and products	3,322	3,427
Total revenue, net	22,894	20,793
Cost of revenue	12,810	12,514
Gross profit	10,084	8,279
Operating expenses:
Selling and marketing	5,460	4,945
Research and development	419	388
General and administrative	3,184	3,047
Total operating expenses	9,063	8,380
Operating income (loss)	1,021	(101)
Interest and other (income) expense, net	137	16
Income (loss) before income taxes	884	(117)
Current tax expense	44	21
Deferred tax expense	257	135
Total income tax expense	301	156
Net income (loss)	583	(273)
Net (income) loss attributable to non-controlling interest	(15)	(465)
Net income attributable to Heska Corporation	$ 598	$ 192
Basic net income per share attributable to Heska Corporation	$ 0.10	$ 0.03
Diluted net income per share attributable to Heska Corporation	$ 0.09	$ 0.03
Weighted average outstanding shares used to compute basic net income per share attributable to Heska Corp.	6,181	5,870
Weighted average outstanding shares used to compute diluted net income per share attributable to Heska Corp	6,869	5,985